Abbott voluntarily pulls obesity drug Meridia from US & Canada

Scrip   

Abbott voluntarily pulls obesity drug Meridia from US & Canada
11 October 2010
Nancy Faigen

Abbott Laboratories has withdrawn its obesity drug Meridia (sibutramine) from the US market at the FDA's request.
Following a review of detailed SCOUT data, agency officials concluded that the drug's modest benefit on weight loss does not outweigh the risk of heart attack or stroke. Health Canada..